Cytosorbents (CTSO) Net Margin (2011 - 2026)
Cytosorbents' (CTSO) quarterly Net Margin came in at 45.85% in Q2 2026, down 6610.0% on a YoY basis from 0.7% in Q2 2025, and up 20.76% quarter-over-quarter from 57.86% in Q1 2026.
Powered by 
Analysis
Cytosorbents (CTSO) Net Margin (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has reported Net Margin for 16 consecutive years, with 45.85% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin fell 6610.0% year-over-year to 45.85%; the trailing twelve-month figure through Jun 2026 stood at 48.94% (down 2161.0% YoY), and the FY2025 full-year result was 22.12%, up 3609.0% from the prior year.
- Net Margin advanced to 45.85% in Q2 2026 per CTSO's latest filing, from 57.86% in the prior quarter.
- Across five years, Net Margin topped out at 20.25% in Q2 2025 and bottomed at 150.42% in Q3 2022.
- Historically, Net Margin has averaged 62.88% across 5 years, with a median of 62.42% in 2023.
- The widest YoY moves for Net Margin: up 7816 bps in 2022, down 8916 bps in 2022.
- Over 5 years, Net Margin stood at 8.16% in 2022, then slumped by 725 bps to 67.31% in 2023, then dropped by 23 bps to 82.69% in 2024, then climbed by 28 bps to 59.53% in 2025, then advanced by 23 bps to 45.85% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 45.85%, 57.86%, and 59.53% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.47% |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | -45.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45.85% |
| Mar 31, 2026 | -57.86% |
| Dec 31, 2025 | -59.53% |
| Sep 30, 2025 | -33.42% |
| Jun 30, 2025 | 20.25% |
| Mar 31, 2025 | -16.95% |
| Dec 31, 2024 | -82.69% |
| Sep 30, 2024 | -32.14% |
| Jun 30, 2024 | -48.56% |
| Mar 31, 2024 | -70.73% |
| Dec 31, 2023 | -67.31% |
| Sep 30, 2023 | -104.34% |
| Jun 30, 2023 | -65.31% |
| Mar 31, 2023 | -77.53% |
| Dec 31, 2022 | -8.16% |
| Sep 30, 2022 | -150.42% |
| Jun 30, 2022 | -128.06% |
| Mar 31, 2022 | -103.16% |
| Dec 31, 2021 | -86.32% |
| Sep 30, 2021 | -65.64% |